VC  5AM Ventures

http://www.5amventures.com





     Office Locations:

28 State St., Suite 2303
Boston, MA 02109
Phone: 857-305-1825
Fax: 857-305-1843

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    5AM Ventures makes seed and early-stage investments in next-generation life science companies. Founded in 2002 by former Bay City Capital principals, 5AM Ventures has offices in Waltham and Menlo Park, CA. The 5AM team takes a hands-on approach to company building. In addition to holding board seats in the majority of its portfolio companies, 5AM is directly involved in company strategy, management recruiting, business development, and fundraising. The 5AM portfolio, built on advanced life science technologies, is diversified among innovative platforms, spinouts from established biotechnology and pharmaceutical companies, and companies developing near-term products. The firm currently has over $685 million under management and is actively investing 5AM Ventures IV, a $250 million raised in 2013.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Andrew J. Schwab Managing Partner
    Arjun Goyal MD Associate
    Brian Daniels MD Venture Partner
    Hannah Chang MD, PhD Associate
    James W. Young PhD Venture Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      04/04/2018


      Arvinas


      CT


      $55,000,000


      Series C


      03/15/2018


      IDEAYA Biosciences


      CA


      $94,000,000


      Series B


      01/04/2018


      Neurogastrx


      CA


      $45,000,000


      Series A


      01/03/2018


      Expansion Therapeutics


      CA


      $55,300,000


      Series A


      01/02/2018


      PEAR Therapeutics


      MA


      $50,000,000


      Series B


      08/01/2017


      Homology Medicines


      MA


      $83,500,000


      Series B


      05/15/2017


      Scientist.com


      CA


      $24,000,000


      


     

    Portfolio companies include:


      Achaogen
        web link


      Alexza Pharmaceuticals
        web link


      Ambrx
        web link


      Arvinas
        web link


      Atterocor
        web link


      Audentes Therapeutics
        web link


      Biodesy
        web link


      Ceterix Orthopaedics
        web link


      Chrono Therapeutics
        web link


      Cidara Therapeutics
        web link


      Cleave Biosciences
        web link


      Crinetics Pharmaceuticals
        web link


      DVS Sciences
        web link


      Envoy Therapeutics
        web link


      Epirus Biopharmaceuticals
        web link


      Expansion Therapeutics
        web link


      Flexion Therapeutics
        web link


      Homology Medicines
        web link


      IDEAYA Biosciences
        web link


      Igenica
        web link


      Ikaria
        web link


      Ilypsa
        web link


      Incline Therapeutics
        web link


      KaloBios
        web link


      Kinestral
        web link


      Kinestral Technologies
        web link


      Marcadia Biotech
        web link


      Neurogastrx
        web link


      Novira Therapeutics
        web link


      Panomics
        web link


      PEAR Therapeutics
        web link


      Pearl Therapeutics
        web link


      Purigen Biosystems
        web link


      Relypsa
        web link


      Rennovia
        web link


      RuiYi
        web link


      Scientist.com
        web link


      scPharmaceuticals
        web link


      Spyryx Biosciences
        web link


      Viveve
        web link


      Wildcat Discovery Technologies
        web link


     

    Recent News:


      There is no recent news for 5AM Ventures.